Remove 2021 Remove Profitability Remove Public Trading
article thumbnail

SaaS M&A Snapshot: Target Market & Buyers

Software Equity Group

The SEG Index, a collection of 116 public SaaS companies, fell by 48.2%. After the unprecedented market highs of 2020 into 2021, it’s natural for founders in this environment to wonder if they’ve missed the boat. Median EV/TTM Revenue Multiple Down from 2021’s high of 7.3x, 2022’s median EV/Revenue multiple of 5.6x

M&A 52
article thumbnail

Public SaaS Company Valuations and What They Mean for Private Companies

Software Equity Group

Public SaaS companies enjoyed an unprecedented run from 2009 through 2021, but last year brought a wave of macroeconomic uncertainty, including rising interest rates, record inflation, supply chain problems, and geopolitical unrest. from 2021 by the end of the year. What is the SEG Index?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley M&A

Although 2022 saw a general decline in M&A activity in the life sciences industry compared to 2021’s frenetic pace (when deal volume was up 52% from 2020 ), life sciences deal flow in 2022 on balance remained strong despite the headwinds. Let’s dig in.

M&A 40
article thumbnail

Technology Services Mergers Update – Q1 2024

Solganick & Co.

Technology research firm, Canalys, expects MSP M&A activity to grow 50% in 2024, returning to 60% of 2021 levels, as the surge in cloud migrations, outsourced IT, and increasing cybersecurity complexity fuel demand. This aligns with the growing need for tailored software solutions.

Mergers 52
article thumbnail

8 Proven Marketing Strategies for Sustainable Growth

Software Equity Group

Our panel comprises leaders well-versed in go-to-market operations for SaaS businesses of all types, from bootstrapped startups to PE-backed and publicly traded companies. All this tracking and reporting allowed us to understand which channels were working and which weren’t and move budget dollars to the more profitable ones.

Sale 52
article thumbnail

Cooley’s 2020 Tech M&A Year in Review

Cooley M&A

Time will tell whether SPACs are a fad, and what the impact on the deal market and pending transactions may be if the demand generated by new SPACs begins to outpace the supply of targets who view a SPAC as a compelling source of capital or avenue to the public markets relative to alternatives. A Different Prescription for Poison Pills.

M&A 40
article thumbnail

Cooley’s 2021 Life Sciences M&A Year in Review

Cooley M&A

Although the COVID-19 pandemic that defined 2020 continued to shape much of the life sciences industry in 2021, the way that it did was markedly different. 2] Examples of this strategy coming to bear in 2021 included Thermo Fisher Scientific’s acquisition of PPD for $17.4 driven assets. term average of approximately 35%.

M&A 40